Details for Patent: 5,462,740
✉ Email this page to a colleague
Summary for Patent: 5,462,740
Title: | Rectally-administered, epileptic-seizure-inhibiting composition |
Abstract: | This invention provides a rectally administered composition for inhibiting epileptic seizure and to its methods of use. The composition contains, in a suitable solvent, an anti-epileptic agent for inhibiting epileptic seizure, a buffer for maintaining pH, and a thickener for imparting a viscosity to the composition effective for rectal administration by injection to a patient in epileptic seizure. |
Inventor(s): | Evenstad; Kenneth L. (Wayzata, MN), O'Neill; Victoria A. (Wayzata, MN), Gorham; Thomas R. (Brooklyn Park, MN) |
Assignee: | Athena Neurosciences, Inc. (San Francisco, CA) |
Application Number: | 08/122,685 |
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 5,462,740
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 5,462,740
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 7686394 | ⤷ Try a Trial | |||
Canada | 2171627 | ⤷ Try a Trial | |||
World Intellectual Property Organization (WIPO) | 9507672 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |